Elixinol Wellness Ltd · ASX:EXL
Elixinol Wellness — FY2019 Earnings Presentation
21 slides from Elixinol Wellness's earnings presentation, Feb 27, 2020
Slide 1: FY2019 Full Year Results
www.elixinolglobal.com FY2019 Full Year Results Elixinol Global Limited ASX: EXL, OTC: ELLXF www.elixinolglobal.com EXL FY2019 RESULTS PRESENTATION
Slide 2: Disclaimer
Disclaimer This presentation contains summary refraining from acting as a result of this operations and business of Elixinol and performance. No representation or information about Elixinol Global information is accepted by Elixinol, any associated entities of Elixinol and certain warranty is made t
Slide 3: Agenda
www.elixinolglobal.com 1 HIGHLIGHTS & BUSINESS REVIEW 4 2 FY2019 FINANCIAL RESULTS 13 3 STRATEGY & OUTLOOK 17 4 Q&A 20 Agenda EXL FY2019 RESULTS PRESENTATION 3
Slide 4: Highlights & Business Review
FY2019 CANNABIS WHO RESULTS BUSINESS FINANCIAL DEFINITION WE ARE OVERVIEW OVERVIEW RESULTS OUTLOOK Q+A HIGHLIGHTS & BUSINESS REVIEW 1 Calm Before, During & After the Storm. Kind of Amazing EXL FY2019 RESULTS PRESENTATION 4
Slide 5: Key highlights for FY2019
HIGHLIGHTS & FY2019 FINANCIAL STRATEGY & Q&A BUSINESS REVIEW HIGHLIGHTS OUTLOOK Key highlights for FY2019 Revenue from Elixinol Strategic partnerships Expanding branded products provides significant global global presence increased by 35% to $16.1m expansion opportunities via of Elixinol branded pro
Slide 6: Who we are
HIGHLIGHTS & FY2019 FINANCIAL STRATEGY & Q&A BUSINESS REVIEW HIGHLIGHTS OUTLOOK Who we are Benefiting health Elixinol is a global leader in the hemp derived CBD industry, innovating, manufacturing and selling Elixinol branded hemp and wellness in derived CBD products communities around the world The
Slide 7: Why we're different
HIGHLIGHTS & FY2019 FINANCIAL STRATEGY & Q&A BUSINESS REVIEW HIGHLIGHTS OUTLOOK Why we’re different We believe Elixinol’s products represent the highest quality in the market 1. Recognised and 2. Diversified revenue 3. Global reach 4. Heritage in hemp established global brand streams and go market E
Slide 8: A diligent approach to ensure Elixinol is well positioned
HIGHLIGHTS & FY2019 FINANCIAL STRATEGY & Q&A BUSINESS REVIEW HIGHLIGHTS OUTLOOK A diligent approach to ensure Elixinol is well positioned A focus on return Refined strategic Simplified business Brand and product on investment focus model refresh Total Elixinol brand refresh to enables Elixinol To de
Slide 9: Refined Elixinol branded product mix
HIGHLIGHTS & FY2019 FINANCIAL STRATEGY & Q&A BUSINESS REVIEW HIGHLIGHTS OUTLOOK Refined Elixinol branded product mix Optimised, customer-led range, with products launching from March 2020 Consumer Products Dietary Supplements Topicals Private Label / Bulk • Tinctures • Elixinol Skin Leveraging indus
Slide 10: Elixinol branded products – the new breed
HIGHLIGHTS & FY2019 FINANCIAL STRATEGY & Q&A BUSINESS REVIEW HIGHLIGHTS OUTLOOK Elixinol branded products – the new breed New Elixinol branded • Elixinol’s focus is on hemp derived CBD formats that consumers in our key markets recognise as supplements product range launching • New Elixinol branded p
Slide 11: Revenue growth in high margin Elixinol branded products
HIGHLIGHTS & FY2019 FINANCIAL STRATEGY & Q&A BUSINESS REVIEW HIGHLIGHTS OUTLOOK Revenue growth in high margin Elixinol branded products Focus on branded products to drive Revenue by Channel higher margins A$ million, 31 December year end Branded / co-branded products 35.0 (eCommerce, Retail, Europe
Slide 12: Growth Drivers
HIGHLIGHTS & FY2019 FINANCIAL STRATEGY & Q&A BUSINESS REVIEW HIGHLIGHTS OUTLOOK Growth Drivers Firmly positioned to drive • Key sales hires to focus on optimising and expanding retail continued growth of distribution partnerships Elixinol’s branded products • New product development with skincare ra
Slide 13: FY2019 Financial Results
FY2019 CANNABIS WHO RESULTS BUSINESS FINANCIAL DEFINITION WE ARE OVERVIEW OVERVIEW RESULTS OUTLOOK Q+A FY2019 FINANCIAL RESULTS 2 A Better Way to Feel Better. Kind of Amazing EXL FY2019 RESULTS PRESENTATION 13
Slide 14: Financial Summary: scale built to support expected growth
HIGHLIGHTS & FY2019 FINANCIAL STRATEGY & Q&A BUSINESS REVIEW HIGHLIGHTS OUTLOOK Financial Summary: scale built to support expected growth Revenue ($m) FY2019 FY2018 • 35% growth in Elixinol branded / co-branded product sales Revenue 27.2 32.5 • 16% decline FY2019 vs FY2018 driven by: • Termination o
Slide 15: Cash Flow: reinvestment to support expected future growth
HIGHLIGHTS & FY2019 FINANCIAL STRATEGY & Q&A BUSINESS REVIEW HIGHLIGHTS OUTLOOK Cash Flow: reinvestment to support expected future growth ($m) FY2019 FY2018 Operating cash flow • Includes $26.4m investment which increased and secured Operating activities (51.0) (5.3) inventory to support future cons
Slide 16: Financial Position: Cash and inventory to support growth
HIGHLIGHTS & FY2019 FINANCIAL STRATEGY & Q&A BUSINESS REVIEW HIGHLIGHTS OUTLOOK Financial Position: Cash and inventory to support growth ($m) 31 Dec 2019 31 Dec 2018 Cash on hand to support future growth Current assets • $20.2m cash on hand Cash and cash equivalents 20.2 42.9 Inventory on hand to re
Slide 17: Strategy & Outlook
FY2019 CANNABIS WHO RESULTS BUSINESS FINANCIAL DEFINITION WE ARE OVERVIEW OVERVIEW RESULTS OUTLOOK Q+A STRATEGY & OUTLOOK 3 Action for Your Bodies Reaction. Kind of Amazing EXL FY2019 RESULTS PRESENTATION 17
Slide 18: Strategic priorities: disciplined approach to driving future growth
HIGHLIGHTS & FY2019 FINANCIAL STRATEGY & Q&A BUSINESS REVIEW HIGHLIGHTS OUTLOOK Strategic priorities: disciplined approach to driving future growth Strategic focus on high margin Growing eCommerce presence Innovation and technology Elixinol branded products • Recent investment in eCommerce platform
Slide 19: Outlook
HIGHLIGHTS & FY2019 FINANCIAL STRATEGY & Q&A BUSINESS REVIEW HIGHLIGHTS OUTLOOK Outlook Stratos Karousos, Elixinol Group CEO stated: “ It’s pleasing to see sales of Elixinol branded products have increased 35% in FY2019. This highlights Elixinol’s leadership team are executing on our refined strateg
Slide 20: Q&A
FY2019 CANNABIS WHO RESULTS BUSINESS FINANCIAL DEFINITION WE ARE OVERVIEW OVERVIEW RESULTS OUTLOOK Q+A Q&A 4 Works as Hard as You Do. Kind of Amazing EXL FY2019 RESULTS PRESENTATION 20
Slide 21: For more information:
www.elixinolglobal.com For more information: Investor relations and media please contact: Ron Dufficy Chief Financial Officer ron.dufficy@elixinolglobal.com www.elixinolglobal.com EXL FY2019 RESULTS PRESENTATION